Unternehmen Biohaven Pharmaceutical Holding Company Ltd.
Aktien
A2DQ7W
VGG111961055
BHVN
Biotechnologie
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
39.61 USD | +3.34% | -14.38% | -73.91% |
Kurzporträt
Mitarbeiterzahl: 928
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03.10.22 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25.10.17 | |
Lisa Stocking
COO | Chief Operating Officer | - | - |
Melissa Beiner
CTO | Chief Tech/Sci/R&D Officer | - | 01.07.17 |
Gastón Ortega
BRD | Director/Board Member | - | 03.10.22 |
Investor Relations Contact | - | 01.01.22 | |
Marianne Frost
LAW | General Counsel | - | - |
Tamara Noonan
PRN | Corporate Officer/Principal | - | - |
Daniel Franjic
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03.10.22 |
Gastón Ortega
BRD | Director/Board Member | - | 03.10.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 107 477 580 | 96 868 157 ( 90,13 %) | 0 | 90,13 % |
Unternehmenskontakt
Biohaven Pharmaceutical Holding Co. Ltd.
215 Church Street Suite 304
06510-1803, New Haven
+284-852-3000
http://biohavenpharma.com/Sektor
% 1. Jan. | Kap. | |
---|---|---|
-73.91% | 541 Mio. | |
+3.13% | 42.11 Mrd. | |
+48.83% | 40.08 Mrd. | |
+8.49% | 40 Mrd. | |
-10.82% | 26.87 Mrd. | |
+8.26% | 24.58 Mrd. | |
-23.69% | 18.44 Mrd. | |
+1.58% | 11.94 Mrd. | |
+32.83% | 11.66 Mrd. | |
+6.63% | 11.01 Mrd. |
- Börse
- Aktien
- A2DQ7W Aktie
- Unternehmen Biohaven Pharmaceutical Holding Company Ltd.